Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Eur Radiol ; 28(12): 5182-5194, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29846804

ABSTRACT

PURPOSE: To compare the efficacy of use of digital breast tomosynthesis (DBT) with standard digital mammography (DM) workup views in the breast cancer assessment clinic. MATERIALS AND METHODS: The Tomosynthesis Assessment Clinic trial (TACT), conducted between 16 October 2014 and 19 April 2016, is an ethics-approved, monocenter, multireader, multicase split-plot reading study. After written informed consent was obtained, 144 females (age > 40 years) who were recalled to the assessment clinic were recruited into TACT. These cases (48 cancers) were randomly allocated for blinded review of (1) DM workup and (2) DBT, both in conjunction with previous DM from the screening examination. Fifteen radiologists of varying experience levels in the Australia BreastScreen Program were included in this study, wherein each radiologist read 48 cases (16 cancers) in 3 non-overlapping blocks. Diagnostic accuracy was measured by means of sensitivity, specificity, and positive (PPV) and negative predictive values (NPV). The receiver-operating characteristic area under the curve (AUC) was calculated to determine radiologists' performances. RESULTS: Use of DBT (AUC = 0.927) led to improved performance of the radiologists (z = 2.62, p = 0.008) compared with mammography workup (AUC = 0.872). Similarly, the sensitivity, specificity, PPV, and NPV of DBT (0.93, 0.75, 0.64, 0.96) were higher than those of the workup (0.90, 0.56, 0.49, 0.92). Most radiologists (80%) performed better with DBT than standard workup. Cancerous lesions on DBT appeared more severe (U = 33,172, p = 0.02) and conspicuous (U = 24,207, p = 0.02). There was a significant reduction in the need for additional views (χ2 = 17.63, p < 0.001) and recommendations for ultrasound (χ2 = 8.56, p = 0.003) with DBT. CONCLUSIONS: DBT has the potential to increase diagnostic accuracy and simplify the assessment process in the breast cancer assessment clinic. KEY POINTS: • Use of DBT in the assessment clinic results in increased diagnostic accuracy. • Use of DBT in the assessment clinic improves performance of radiologists and also increases the confidence in their decisions. • DBT may reduce the need for additional views, ultrasound imaging, and biopsy.


Subject(s)
Breast Neoplasms/diagnosis , Mammography/methods , Mass Screening/methods , Radiographic Image Enhancement/methods , Australia/epidemiology , Breast Neoplasms/epidemiology , Female , Humans , Incidence , ROC Curve
2.
Ann Rheum Dis ; 71(1): 26-32, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22135412

ABSTRACT

BACKGROUND: Obesity is an important risk factor for knee osteoarthritis (OA), Weight loss can reduce the symptoms of knee OA. No prospective studies assessing the impact of weight loss on knee cartilage structure and composition have been performed. OBJECTIVES: To assess the impact of weight loss on knee cartilage thickness and composition. METHODS: 111 obese adults were recruited from either laparoscopic adjustable gastric banding or exercise and diet weight loss programmes from two tertiary centres. MRI was performed at baseline and 12-month follow-up to assess cartilage thickness. 78 eligible subjects also underwent delayed gadolinium-enhanced MRI of cartilage (dGEMRIC), an estimate of proteoglycan content. The associations between cartilage outcomes (cartilage thickness and dGEMRIC index) and weight loss were adjusted for age, gender, body mass index (BMI) and presence of clinical knee OA. RESULTS: Mean age was 51.7 ± 11.8 years and mean BMI was 36.6 ± 5.8 kg/m(2); 32% had clinical knee OA. Mean weight loss was 9.3 ± 11.9%. Percentage weight loss was negatively associated with cartilage thickness loss in the medial femoral compartment in multiple regression analysis (ß=0.006, r(2)=0.19, p=0.029). This association was not detected in the lateral compartment (r(2)=0.12, p=0.745). Percentage weight loss was associated with an increase in medial dGEMRIC in multiple regression analysis (ß=3.9, r(2)=0.26; p=0.008) but not the lateral compartment (r(2)=0.14, p=0.34). For every 10% weight loss there was a gain in the medial dGEMRIC index of 39 ms (r(2)=0.28; p=0.014). The lowest weight loss cut-off associated with reduced medial femoral cartilage thickness loss and improved medial dGEMRIC index was 7%. CONCLUSIONS: Weight loss is associated with improvements in the quality (increased proteoglycan content) and quantity (reduced cartilage thickness losses) of medial articular cartilage. This was not observed in the lateral compartment. This could ultimately lead to a reduced need for total joint replacements and is thus a finding with important public health implications.


Subject(s)
Cartilage, Articular/pathology , Knee Joint/pathology , Obesity/pathology , Osteoarthritis, Knee/pathology , Weight Loss/physiology , Adult , Anthropometry/methods , Body Mass Index , Epidemiologic Methods , Female , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Obesity/complications , Obesity/therapy , Osteoarthritis, Knee/etiology
3.
Australas Radiol ; 49(5): 404-6, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16174180

ABSTRACT

Tear of the distal biceps brachii tendon is an uncommon injury. Ultrasound evaluation of the distal tendon using an anterior approach is often difficult because of technical factors. We describe a new method of ultrasound evaluation of the distal biceps tendon insertion. This involves a posterior approach with the forearm pronated. With pronation of the forearm, the radial tuberosity faces posteriorly, bringing the distal biceps tendon insertion into view. A surgically proven case of distal biceps tendon tear is presented to illustrate our technique.


Subject(s)
Arm Injuries/diagnostic imaging , Tendon Injuries/diagnostic imaging , Adult , Arm Injuries/surgery , Humans , Male , Tendon Injuries/surgery , Ultrasonography
4.
Neurology ; 63(6): 1053-8, 2004 Sep 28.
Article in English | MEDLINE | ID: mdl-15452297

ABSTRACT

BACKGROUND: Glycogen storage disease type IV (GSD-IV) is a clinically heterogeneous autosomal recessive disorder due to glycogen branching enzyme (GBE) deficiency and resulting in the accumulation of an amylopectin-like polysaccharide. The typical presentation is liver disease of childhood, progressing to lethal cirrhosis. The neuromuscular form of GSD-IV varies in onset (perinatal, congenital, juvenile, or adult) and severity. OBJECTIVE: To identify the molecular bases of different neuromuscular forms of GSD-IV and to establish possible genotype/phenotype correlations. METHODS: Eight patients with GBE deficiency had different neuromuscular presentations: three had fetal akinesia deformation sequence (FADS), three had congenital myopathy, one had juvenile myopathy, and one had combined myopathic and hepatic features. In all patients, the promoter and the entire coding region of the GBE gene at the RNA and genomic level were sequenced. RESULTS: Nine novel mutations were identified, including nonsense, missense, deletion, insertion, and splice-junction mutations. The three cases with FADS were homozygous, whereas all other cases were compound heterozygotes. CONCLUSIONS: This study expands the spectrum of mutations in the GBE gene and confirms that the neuromuscular presentation of GSD-IV is clinically and genetically heterogeneous.


Subject(s)
1,4-alpha-Glucan Branching Enzyme/genetics , Genetic Heterogeneity , Glycogen Storage Disease Type IV/genetics , Mutation , 1,4-alpha-Glucan Branching Enzyme/chemistry , 1,4-alpha-Glucan Branching Enzyme/deficiency , Adult , Age of Onset , Amino Acid Substitution , Cells, Cultured/enzymology , Child , Child, Preschool , Consanguinity , DNA/genetics , DNA Mutational Analysis , Erythrocytes/enzymology , Fatal Outcome , Fibroblasts/enzymology , Genotype , Glycogen Storage Disease Type IV/enzymology , Glycogen Storage Disease Type IV/epidemiology , Glycogen Storage Disease Type IV/pathology , Humans , Hydrogen Bonding , Hydrophobic and Hydrophilic Interactions , Infant , Infant, Newborn , Liver/pathology , Models, Molecular , Muscles/enzymology , Muscles/pathology , Phenotype , Protein Conformation , RNA Splice Sites/genetics , Sequence Deletion
5.
Biol Neonate ; 86(3): 165-9, 2004.
Article in English | MEDLINE | ID: mdl-15237239

ABSTRACT

BACKGROUND: Coenzyme Q10 has been recognized as an important antioxidant factor besides its main role in bioenergetic metabolism. CoQ10 tissue levels depend both on exogenous dietetic intake and on endogenous biosynthesis, as this compound can be partly synthesized in human cells. Q10 plasma levels reflect the tissue content of the coenzyme and can be used to evaluate the presence of this compound in the human organism. DESIGN/METHODS: Aim of the study was to measure CoQ10 plasmatic levels in a newborn breast-fed population and to compare them to CoQ10 levels in a newborn formula-fed population in order to verify whether changes in CoQ10 plasmatic contents could be related to a different dietetic intakes. We measured CoQ10 plasmatic levels in 25 healthy term neonates with different dietetic intakes: 15 breast-fed and 10 bottle-fed with a common infant formula. These infants were evaluated prospectively during the first month of life. The analyses were performed on the mothers' blood samples and cord blood samples at the time of delivery, then on infants at 4 and 28 days of age. RESULTS: Our results showed markedly reduced Q10 levels in cord blood samples compared to maternal Q10 plasmatic levels at the time of delivery, suggesting placental impermeability towards this molecule or increased fetal utilization during labor and delivery. At 4 days of age Q10 levels had increased in both groups of neonates, but significantly more in breast-fed infants compared to formula-fed babies (p <0.05). At 4 weeks of age no significant changes occurred in breast-fed infants, while values increased significantly in formula-fed infants (p <0.05). The content of Q10 in breast milk samples was lower than in infant formula. CONCLUSIONS: The results of this study show that CoQ10 plasmatic levels are at least partly influenced by the exogenous dietetic supply.


Subject(s)
Breast Feeding , Infant Formula , Ubiquinone/analogs & derivatives , Ubiquinone/blood , Aging , Coenzymes , Diet , Female , Fetal Blood/chemistry , Gestational Age , Humans , Infant Nutritional Physiological Phenomena , Infant, Newborn , Male , Pregnancy
6.
Biol Neonate ; 86(2): 104-7, 2004.
Article in English | MEDLINE | ID: mdl-15133315

ABSTRACT

BACKGROUND: Oxygen (O2) plays a critical role in the O2-reduction reactions indispensable for life, but can produce free radicals that are involved in many diseases. Coenzyme Q10 (CoQ10), acting as a redox carrier in the respiratory chain, occupies a central position in the energy metabolism and oxidative defence. Neonates seem to be very subjected to oxidative stress because of their deficient antioxidant systems. DESIGN/METHODS: The aim of the study was to verify whether the mode of delivery may affect CoQ10 levels in the mother and neonate, and thus influence the risk of oxidative damage in the newborn. We measured CoQ10 levels in maternal plasma and cord blood at birth after three different modes of delivery (45 term healthy pregnancies): (1) vaginal in room air (VD) (n = 15); (2) elective caesarean section with general anaesthesia (50% O2 and 50% N2O) (CSg) (n = 15), and (3) elective caesarean section with spinal anaesthesia without O2 (CSs) (n = 15). Our results showed higher levels of Q10 in mothers and neonates with VD (1.29 +/- 0.43 and 0.15 +/- 0.06 microg/ml, respectively) or CSs (1.15 +/- 0.28 and 0.24 +/- 0.06 microg/ml, respectively) when compared to CSg (0.74 +/- 0.28 and 0.07 +/- 0.03 microg/ml, respectively) (p < 0.01). CONCLUSIONS: These data demonstrate that the mode of delivery may affect CoQ(10) levels in mothers and neonates, and thus influence the risk of oxidative damage in the newborn.


Subject(s)
Delivery, Obstetric/methods , Fetal Blood/chemistry , Ubiquinone/blood , Anesthesia, General , Anesthesia, Obstetrical , Anesthesia, Spinal , Cesarean Section , Female , Humans , Oxidative Stress , Pregnancy , Risk Factors
8.
J Inherit Metab Dis ; 27(5): 609-19, 2004.
Article in English | MEDLINE | ID: mdl-15669676

ABSTRACT

Glycogenosis type IV is an autosomal recessive disease, exceptionally diagnosed at birth: only very few reports of the fatal perinatal neuromuscular form have been described. We report on two sibling male newborns who died at 10 and 4 weeks of age with clinical signs of a systemic storage disease. Prenatal history included polyhydramnios, reduced fetal movements and fetal hydrops, and Caesarean section was performed at 36 weeks of gestational age because of fetal distress. At birth, both babies showed severe hypotonia, hyporeflexia and no spontaneous breathing activity. They never showed active movements, sucking and swallowing and were respirator-dependent until death. A muscle biopsy revealed, in both patients, the presence of PAS-positive and partially diastase-resistant cytoplasmic inclusions containing granular and filamentous amylopectin-like material. This suggested that the stored material consisted of abnormal glycogen. At autopsy, ultrastructural examination of cardiac and skeletal muscle, liver, kidney and brain showed PAS-positive diastase-resistant eosinophilic cytoplasmic inclusions. Determination of branching enzyme activity, in cultured fibroblasts from the second patient, showed markedly reduced enzyme activity, confirming diagnosis of glycogenosis type IV. Our patients showed the full spectrum of both prenatal signs (hydrops, polyhydramnios) and postnatal signs (hypotonia, hyporeflexia, absence of active movements, cardiomegaly), which have been reported previously. They suffered from a very severe form of glycogenosis type IV with clinical and histological involvement of many tissues and organs. Diagnosis was accomplished on the second baby and required several biochemical and histological studies, in order to rule out both neuromuscular disorders and the most common storage diseases with neonatal onset. In our experience, the correct interpretation of the histological findings was essential in the search for the diagnosis.


Subject(s)
Glycogen Storage Disease Type IV/diagnosis , Glycogen Storage Disease Type IV/genetics , Age of Onset , Autopsy , Central Nervous System/metabolism , Cytoplasm/metabolism , Family Health , Fatal Outcome , Genes, Recessive , Glycogen/blood , Glycogen Storage Disease Type IV/metabolism , Humans , Infant , Infant, Newborn , Male , Muscle, Skeletal/pathology , Tissue Distribution
9.
Acta Paediatr ; 87(6): 695-8, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9686666

ABSTRACT

We describe the cases of two premature infants carrying a central venous line who developed on the fourth day of life a catheter related intracardiac thrombus. Although they were clinically asymptomatic we opted for thrombolytic treatment considering the potential risks of this situation. Treatment with recombinant tissue plasminogen activator (rt-PA) was performed for one day in the first case and for three days in the second one, in association with fresh frozen plasma. Thrombus dissolution occurred in both patients and no adverse effects were noted. In our experience tissue plasminogen activator was a therapy acceptably safe and effective inducing clot lysis in very low birthweight neonates into critical situations.


Subject(s)
Catheterization, Central Venous/adverse effects , Diseases in Twins/therapy , Heart Diseases/drug therapy , Infant, Premature , Plasminogen Activators/administration & dosage , Thrombolytic Therapy/methods , Thrombosis/drug therapy , Tissue Plasminogen Activator/administration & dosage , Disease-Free Survival , Diseases in Twins/etiology , Echocardiography , Fatal Outcome , Fetal Distress/therapy , Fetal Growth Retardation/therapy , Heart Diseases/diagnostic imaging , Heart Diseases/etiology , Humans , Infant, Newborn , Male , Thrombosis/diagnostic imaging , Thrombosis/etiology
10.
Aust N Z J Surg ; 67(9): 630-3, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9322701

ABSTRACT

BACKGROUND: Rotator cuff surgery is facilitated by accurate pre-operative information regarding the presence and size of cuff tears, and the extent of any cuff retraction or lamination. METHODS: A total of 117 consecutive patients who underwent shoulder ultrasound followed by surgical management were assessed, and the pre-operative ultrasound diagnoses were correlated with the operative findings. RESULTS: Ultrasound was found to be reliable for the detection of full-thickness cuff tears (positive predictive value 96%). In the assessment of partial thickness tears, ultrasound produced few false positives, but failed to diagnose a significant proportion of these lesions. Lamination and other interstitial cuff pathology were not reliably detected by ultrasound. In the diagnosis of subacromial impingement, ultrasound produced few false positives (positive predictive value 95%), but did produce a significant number of false negative results (negative predictive value 66%). CONCLUSIONS: Ultrasound is cheaper than MRI and arthrography, and is both non-invasive and 'dynamic'. It is reliable in the diagnosis of full-thickness cuff tears and is a useful adjunct in the diagnosis of cuff impingement and partial thickness tears, but is very much operator-dependent.


Subject(s)
Preoperative Care , Rotator Cuff Injuries , Adolescent , Adult , Aged , Clinical Competence , Female , Humans , Male , Middle Aged , Reproducibility of Results , Sensitivity and Specificity , Ultrasonography/economics , Ultrasonography/standards , Wounds and Injuries/classification , Wounds and Injuries/diagnostic imaging , Wounds and Injuries/surgery
12.
Australas Radiol ; 28(4): 335-8, 1984 Nov.
Article in English | MEDLINE | ID: mdl-6535570
SELECTION OF CITATIONS
SEARCH DETAIL
...